---
---

# 21 U.S.C., USLM ref /us/usc/t21/ch9/schVII/ptC/spt5

* Portions Copyright © 2016 the authors of the https://github.com/publicdocs project.
  Use of this file is subject to the NOTICE at [https://github.com/publicdocs/uscode/blob/master/NOTICE](https://github.com/publicdocs/uscode/blob/master/NOTICE)
* See the [Document Metadata](././../../../../../../..//README.md) for more information.
  This file is generated from historical government data; content and/or formatting may be inaccurate and out-of-date and should not be used for official purposes.

----------
----------

[Previous](./../../../../../../..//us/usc/t21/ch9/schVII/ptC/spt4/m__us_usc_t21_s379j–13.md) | [Next](./../../../../../../..//us/usc/t21/ch9/schVII/ptC/spt5/m__us_usc_t21_s379j–21.md) | [Root of Title](./../../../../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fch9%2FschVII%2FptC%2Fspt5)

##### subpart 5—fees relating to generic new animal drugs

 __Termination of Subpart__ 

    For termination of subpart by section 206(a), (b) of [Pub. L. 113–14][/us/pl/113/14], see Termination Date notes set out under sections 379j–21 and 379j–22 of this title.

----------

[Previous](./../../../../../../..//us/usc/t21/ch9/schVII/ptC/spt4/m__us_usc_t21_s379j–13.md) | [Next](./../../../../../../..//us/usc/t21/ch9/schVII/ptC/spt5/m__us_usc_t21_s379j–21.md) | [Root of Title](./../../../../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fch9%2FschVII%2FptC%2Fspt5)

----------
----------

[/us/pl/113/14]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F113%2F14


